SIGNUP FOR
NEWSLETTER
TSX: HSM
NASDAQ: HSDT
Call us: +1 877-564-0008
About
Back
Overview
Meet Our Team
Advisory Board
Scientific Interests
Divisions
Back
Overview
Helius Medical
Back
The PoNS Device
Investor Relations
Back
Overview
Stock Info
Events
Back
Upcoming Events
Past Events
Code of Conduct
Corporate Documents
Committee Charters
SEC Filings
Financial Information
Back
2019
Back
Q2 2019
Q1 2019
2018
Back
Q4 2018
Q3 2018
Q2 2018
Q1 2018
2017
Back
Q4 2017
Q3 2017
Q2 2017
Q1 2017
2016
Back
Q3 2016
Q2 2016
Q1 2016
2015
Back
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Investor FAQ
Newsroom
Back
News Releases
Back
2021
2020
2019
2018
Archive
Back
2017
2016
2015
2014
In the News
Back
HMT Coverage
Related Science
Media Resources
Our Research
Back
Overview
Clinical Trials
Peer-Reviewed Publications
Words to Know
Research Partners
Contact
Back
Contact HMT
Subscribe Newsletter
Careers
Back
Home
Newsroom
News Releases
Archive
Menu
News Releases
2021
2020
2019
2018
Archive
2017
2016
2015
2014
In the News
HMT Coverage
Related Science
Media Resources
Stock Quote - HSM-T
*Delayed quote courtesy of Google.
Stock Quote - HSDT
*Delayed quote courtesy of Google.
2017 News Releases
Filters
- Select Tag -
Clinical News
Corporate News
Filter
List of articles in category 2017 News Releases
Title
Date
Helius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and Clinical
09 Feb, 2017
Helius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PA
14 Aug, 2017
Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA
17 Nov, 2017
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement
29 Dec, 2017
Helius Medical Technologies Announces Closing of Second Tranche of Private Placement
28 Dec, 2017
Helius Medical Technologies Announces Closing of First Tranche of Private Placement
22 Dec, 2017
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
08 Nov, 2017
Helius Medical Technologies to Report Results from Traumatic Brain Injury Clinical Trials
08 Nov, 2017
Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017
01 Nov, 2017
Helius Medical Technologies Highlights Publication of Stroke Study From The Royal Melbourne Hospital in Australia Using Investigational PoNS™ Device
02 Oct, 2017
Helius Medical Technologies Appoints Dane C. Andreeff to Board of Directors
14 Sep, 2017
Helius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US Army
13 Sep, 2017
Helius Medical Technologies Announces Newly Constituted Scientific Advisory Board
31 Jul, 2017
Helius Medical Technologies and the United States Army Medical Research and Materiel Command Announce Last Subject Enrolled In TBI Registrational Clinical Trial
13 Jul, 2017
Helius Medical Announces Research Conducted at the Tactile Communication and Neurorehabilition Laboratory (TCNL) Using PoNS™Therapy
28 Jun, 2017
Helius Medical Announces Closing of CAD$7.0 Million Private Placement
28 Jun, 2017
Helius Medical Technologies Receives First of Two Human Performance Patents
23 May, 2017
Helius Medical Technologies Receives Two Medical Method Patents
17 Apr, 2017
Helius Medical Technologies Signs 5-Year Lease for Corporate Headquarters in Newtown, PA
10 Apr, 2017
Advocates Reveal State of Progress, Need for More Clinical Research During Brain Injury Awareness Month
01 Mar, 2017
Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference
22 Feb, 2017
Helius Medical Technologies Inc. Closes C$12.5 Million Public Offering of Class A Common Stock, Including Full Exercise of Over-Allotment Option
16 Feb, 2017
Helius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common Stock
09 Feb, 2017
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock
08 Feb, 2017
Helius Medical Technologies Announces Resignation of Director
03 Feb, 2017
Helius Medical Technologies Announces Filing of Final MJDS Base Shelf Prospectus
26 Jan, 2017
Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
16 Jan, 2017
Helius Medical Technologies Announces Launch of Fifth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
10 Jan, 2017
Helius Medical Technologies announces that its shelf registration filed on Form S-3 with the US Securities and Exchange Commission (SEC) has been made effective
09 Jan, 2017